Health & Fitness
Health and Fitness
Health and Fitness
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010 GenMark Diagnostics Schedules Second Quarter Earnings Release and Conference Call for August 9, 2010
CARLSBAD, Calif.--([ BUSINESS WIRE ])--GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter 2010 financial results after market close on Monday, August 9, 2010. Management will hold a conference call to review the company's second quarter 2010 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website at [ www.genmarkdx.com ] under the investor webcast section and will be archived for future reference.
To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number "87984618" approximately five minutes prior to the start time.
About GenMark
GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients and is focused on developing and commercializing its eSensor detection technology. GenMarka™s XT-8 System is designed to support a broad range of molecular diagnostic tests with a compact and easy-to-use workstation and self-contained, disposable test cartridges. GenMark has developed four diagnostic tests for use with the XT-8 System, including its Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test and Thrombophilia Risk Test which have received clearance from the Food and Drug Administration.
